Ana Garrido-Castro

21PUBLICATIONS
137CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 30, 2026
Association between self-reported breast cancer knowledge and clinical trial participation in patients with triple-negative breast cancer.

|Jun 16, 2026
Tumor-Associated Platelets Suppress T-cell Function and Promote Immune Evasion in TNBC via the P-selectin/P-selectin Glycoprotein Ligand 1 Pathway.

|Jun 05, 2026
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

|May 15, 2026
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial.

|May 16, 2025
Clinicogenomic Characterization of Inflammatory Breast Cancer.

Nolan Priedigkeit, Beth Harrison, Robert Shue

|Oct 09, 2024
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution.

Amy E Schade, Naiara Perurena, Yoona Yang

Pageof 4

Frequent Collaborators

10 joint publications

Sara M Tolaney

5 joint publications

Nancy U Lin

4 joint publications

Filipa Lynce

4 joint publications

Paolo Tarantino